CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
NCT01386502
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
NIH
Sponsor class
Conditions
Breast Cancer
Colon Cancer
Pancreatic Cancer
Sarcoma
Ovarian Cancer
Interventions
BIOLOGICAL:
p53: 264-272 peptide
DRUG:
CT-011
Sponsor
National Cancer Institute (NCI)